Propanc Biopharma, Inc. (PPCB)
NASDAQ · Manufacturing · Pharmaceutical preparations
$0.6500+$0.0482 (+8.01%) on the dayAs of the close; data may be delayed.
PPCB price, last 12 months
Key stats
- Previous close
- $0.6018
- Open
- $0.6155
- Day range
- $0.5800 – $0.6698
- 52-week range
- $0.5600 – $52.50
- Volume
- 379.1K
- Avg volume (20 days)
- 545.6K
- Market cap
- $1.4M
Performance
1W+6.6%
1M−39.3%
3M−55.8%
6M−75.9%
YTD−95.2%
1Y−98.7%
vs S&P 500, 1Y−115.4 pts
Technicals and fundamentals
About Propanc Biopharma, Inc.
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $1.4M